Docebo (DCBO) Cost of Revenue (2019 - 2026)

Docebo (DCBO) has reported Cost of Revenue for 8 consecutive years, with $14.4 million the latest figure, recorded in Q1 2026.

• Quarterly Cost of Revenue rose 25.96% year-over-year to $14.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $50.8 million (up 18.81% YoY) and the FY2025 annual result came in at $47.9 million, up 15.88% from the prior year.
• Cost of Revenue improved to $14.4 million in Q1 2026 per DCBO's latest filing, from $12.7 million in the prior quarter.
• Over the last five years, Cost of Revenue for DCBO reached as high as $14.4 million in Q1 2026 and fell as low as $6.6 million in Q1 2022.
• A 5-year average of $9.8 million and a median of $9.9 million in 2024 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2022 — Cost of Revenue jumped 69.57% — and 2025, when it gained 12.94%.
• Year by year, Cost of Revenue stood at $7.5 million in 2022, then grew by 23.28% to $9.3 million in 2023, then grew by 15.07% to $10.6 million in 2024, then gained by 19.62% to $12.7 million in 2025, then climbed by 12.66% to $14.4 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $14.4 million, $12.7 million, and $12.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.